Misonix Features New BoneScalpel MIS at SpineWeek 2016 in Singapore

FARMINGDALE, N.Y., May 16, 2016 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, today announced that it will be exhibiting at the 2016 SpineWeek conference in Singapore, to take place from May 16 to May 20, 2016.

Surgeon attendees at this important global conference from all over the world will have the opportunity to trial the BoneScalpel, and the newly launched minimally invasive spinal solution BoneScalpel MIS, in a hands-on session at the exhibition.   

Scott Ludecker, Senior Vice President of Global Sales & Marketing, commented, "Advancements like BoneScalpel MIS are enabling minimally invasive spine procedures that have less post-operative pain, are safer, and potentially return patients to their normal activities sooner than otherwise possible with open procedures. Additionally, the BoneScalpel MIS has been referred to as a 'game changer' by a number of opinion leading surgeons and continues to gain acceptance around the world. Participation in SpineWeek this year will serve as a great forum for Misonix to continue its growth into the Asian markets."

"SpineWeek 2016 in Singapore represents a great opportunity for the team at Misonix to formally introduce our newest surgical solutions to our expanding base of surgeon customers already using BoneScalpel in this part of the world. We will also have the opportunity to demonstrate the unique clinical benefits of BoneScalpel to new customers in hands-on sessions. Misonix recently reported worldwide revenues from BoneScalpel increased 41% in our third quarter. We look forward to continuing to build on this exciting growth with the addition of new surgeon customers as a result of their hands-on experience at SpineWeek." added Michael A. McManus Jr., President and Chief Executive Officer of Misonix.